Evidence map›Paper›PMID 41994676›Full record

ArticleCureus2026

Clinical and Genetic Characterization of a Patient With SEC63-Related Autosomal Dominant Polycystic Liver Disease and an IFT140 Pathogenic Variant Associated With Polycystic Kidney Disease.

Alan G Ortega-Macías, Udita Gupta, Tomas Escobar Gil, Jawairia Memon, Pablo R García

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alan G Ortega-MacíasInternal Medicine, University of New Mexico School of Medicine, Albuquerque, USA.
Udita GuptaGastroenterology and Hepatology, University of New Mexico School of Medicine, Albuquerque, USA.
Tomas Escobar GilInternal Medicine, University of New Mexico School of Medicine, Albuquerque, USA.
Jawairia MemonGastroenterology and Hepatology, University of New Mexico School of Medicine, Albuquerque, USA.
Pablo R GarcíaNephrology, University of New Mexico School of Medicine, Albuquerque, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 40-year-old female with a family history of polycystic kidney disease presented for evaluation. She was originally diagnosed with liver cysts in 2015 following an emergency department visit for suspected cyst rupture. Laboratory studies demonstrated preserved renal and hepatic function, with a creatinine level of 0.65 mg/dL and an estimated glomerular filtration rate (eGFR) of 114 mL/min/1.73 m². Abdominal MRI revealed numerous hepatic cysts, the largest measuring 12.9 × 10.8 cm, along with multiple bilateral renal cysts. The largest renal cyst measured 5.2 cm and was haemorrhagic and exophytic. Genetic testing identified heterozygous pathogenic variants in both SEC63 and IFT140. The patient is currently managed with serial imaging surveillance for hepatic cyst burden, portal hypertension, and total kidney volume. This case illustrates a rare double-hit genetic entity. While SEC63 mutations rarely involve the kidneys, the co-existence of an IFT140 variant likely contributed to the development of bilateral renal cysts. This report emphasizes the role of comprehensive genetic testing in atypical polycystic presentations and highlights the importance of multidisciplinary monitoring in complex ciliopathies. Informed consent was obtained for publication of this case report.

Indexed as

autosomal dominant polycystic kidney and liver diseaseciliopathygenetic mutationhepatic cystsift140intraflagellarkidney cystspathogenic variantprimary ciliumsec63

Identifiers

PMID41994676
PMCPMC13081031

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.